<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestion xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionVersion>
        <isActive>true</isActive>
        <name>Lanadelumab_Renewal_RenewalCriteria_Q15</name>
        <optionSourceResponseValue>false</optionSourceResponseValue>
        <questionText>Definition: Continued response is defined as no increase in the average number of HAE attacks per month for which acute
injectable treatment was received compared with the average number of attacks per month observed prior to initiating
treatment with lanadelumab.</questionText>
        <responseValues>Yes
No</responseValues>
        <status>Active</status>
        <versionNumber>1</versionNumber>
    </assessmentQuestionVersion>
    <dataType>Radio</dataType>
    <developerName>Lanadelumab_Renewal_RenewalCriteria_Q15</developerName>
    <name>Lanadelumab_Renewal_RenewalCriteria_Q15</name>
    <questionCategory>Demographic</questionCategory>
</AssessmentQuestion>
